Leia Sensory Prosthesis for Peripheral Neuropathy
(MYN-L001-002 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a US-specific pilot study to evaluate the short- and long-term effects of the investigational MYNERVA Leia Sensory Prosthesis on gait, neuropathic symptoms and quality of life in US adults with peripheral neuropathy, and to capture insights on the device's usability and perceived clinical effects.
Are You a Good Fit for This Trial?
This trial is for adults in the U.S. who have peripheral neuropathy (nerve damage causing numbness, tingling, or weakness). Participants should be able to walk and use a wearable device. People with conditions that could interfere with using the device may not be eligible.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- MYNERVA Leia Sensory Prosthesis
Trial Overview
The study is testing the MYNERVA Leia Sensory Prosthesis, a new wearable device designed to help people with nerve damage improve walking and reduce symptoms. Researchers will look at both short- and long-term effects as well as user experience.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants use the device during a single supervised session at the clinic
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mynerva Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.